U.S. Hospitality Stock News

In January 2026, Guardant Health reported unaudited revenue of approximately US$280 million for Q4 and US$981 million for 2025, reflecting strong year-on-year growth across its oncology and Shield colorectal cancer screening tests. At the same time, TRICARE’s decision to cover Guardant’s FDA-approved Shield blood test for colorectal cancer screening with no copay for eligible active-duty service members and families significantly broadens access to this non-invasive screening option within...

Why Avnet Stock Is On Investors’ Radar Avnet (AVT) has attracted fresh attention after recent share price moves, with a 2.3% gain over the past week and about 4.8% over the past month offering a timely moment to reassess the stock. See our latest analysis for Avnet. The recent 1-day share price return of 2.26% and 30-day share price return of 4.75%, against a flatter 90-day share price picture, sit alongside a 1-year total shareholder return that is roughly unchanged and stronger 3-year and...

As the U.S. stock market experiences fluctuations with AI stocks cooling off and major indexes like the Dow Jones wavering, investors are closely watching for opportunities in a climate of mixed economic signals and steady Treasury yields. In this environment, identifying undervalued stocks becomes crucial as they can offer potential value by trading below their intrinsic worth, providing a strategic entry point for those looking to navigate current market conditions effectively.

As the U.S. stock market experiences fluctuations with AI stocks cooling off and major indexes wavering, investors are keenly observing companies that demonstrate resilience and growth potential. In this environment, growth companies with substantial insider ownership and strong revenue growth stand out as promising candidates for those seeking stability and potential upside in their investment portfolios.

As the AI stock rally cools, major U.S. indexes have been wavering, reflecting a broader market uncertainty. For investors willing to explore beyond well-known stocks, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. Despite being considered a somewhat outdated term, penny stocks remain relevant for those seeking affordable entry points with potential growth prospects and financial resilience.

In recent days, Asana reported third-quarter fiscal 2026 results that were ahead of expectations, while sector-wide worries about AI, commoditization, and geopolitical tensions weighed on the broader enterprise software group. The reaction highlights how investor sentiment toward Asana is currently being driven more by industry-wide concerns and competitive pressures than by changes in its own operating performance. We’ll now explore how sector-wide concerns about commoditization and...

Product launch at World of Concrete puts focus on SWK’s tools business Stanley Black & Decker (SWK) is attracting fresh attention after its DEWALT brand unveiled new POWERSHIFT concrete tools at the 2026 World of Concrete Trade Show, highlighting battery tech, safety features, and jobsite productivity. See our latest analysis for Stanley Black & Decker. The DEWALT POWERSHIFT launch comes at a time when momentum in Stanley Black & Decker’s shares has been picking up. The 30 day share price...

If you are wondering whether Alexandria Real Estate Equities is priced attractively right now, you are not alone, especially with so much attention on real estate stocks and their underlying assets. The share price recently closed at US$57.26, with returns of 7.5% over 7 days and 21.9% over 30 days. However, the 1 year, 3 year, and 5 year returns of negative 39.1%, negative 56.8%, and negative 59.0% show a very different picture. These moves have put Alexandria Real Estate Equities back on...

Why Radware’s AI Security Discovery Matters for Investors Radware (RDWR) recently reported the discovery of ZombieAgent, a zero-click indirect prompt injection vulnerability in OpenAI’s Deep Research agent, exposing risks such as invisible data theft and persistent agent hijacking for enterprise users. The company plans to publish full technical details and defense guidance through its Security Research Center. This keeps the focus on how its cybersecurity capabilities align with demand for...

Ascendis Pharma (NasdaqGS:ASND) is back in focus after releasing Week 52 topline data from its Phase 2 COACH trial, in which once weekly TransCon CNP and TransCon hGH combination therapy produced durable growth and proportionality benefits. See our latest analysis for Ascendis Pharma. Investors appear to be weighing the fresh COACH trial readout against Ascendis Pharma’s recent share price performance. The stock is at US$215.04 after a 3.0% 7 day share price gain and a 63.4% 1 year total...

If you are wondering whether DNOW's current share price gives you enough value for the risk you are taking, this article walks through what the numbers are actually saying. The stock last closed at US$14.34, with returns of 4.7% over 7 days, 4.1% over 30 days, 7.3% year to date, 5.7% over 1 year, 16.3% over 3 years and 76.2% over 5 years, which many investors use as a starting point when thinking about potential value or shifting risk perceptions. Recent attention on DNOW has been shaped by...

Value Holdings Management’s recent purchase of 98,289 shares in Euronet Worldwide (EEFT) follows a quarter in which revenue grew 4% and adjusted EPS rose 19%, with management guiding to 12% to 16% full year EPS growth. See our latest analysis for Euronet Worldwide. Even with the latest earnings update and fresh interest from Value Holdings Management, Euronet Worldwide’s share price has been under pressure, with a 90 day share price return showing a 14.47% decline and a 1 year total...

Canaan (CAN) is back in the spotlight after reporting unaudited operating results that include higher deployed hashrate, record bitcoin and ethereum holdings, and a renewed US$30 million share repurchase program. See our latest analysis for Canaan. Despite the recent operational updates and the new Canadian heat reuse pilot, momentum in the stock has been mixed, with a 3.29% 30 day share price return, a 48.74% 90 day share price decline, and a 56.84% 1 year total shareholder return...

If you are wondering whether Simon Property Group is still reasonably priced at around US$182, this article walks through what the current share price might be implying about its value. The stock is close to its recent level at US$182.31, with a 1% decline over the last 7 days, a flat 0.1% decline over 30 days, and returns of 10.9% over 1 year, 77.3% over 3 years and 151.6% over 5 years, which may have shifted how investors are thinking about risk and reward. Recently, headlines around Simon...

CarGurus (CARG) has been drawing attention after recent share price moves, with the stock now around US$34.74. For investors, the key question is how this lines up with the company’s fundamentals. See our latest analysis for CarGurus. Recent trading has been choppy, with a 7 day share price return of a 10.05% decline and a 30 day share price return of a 9.03% decline. However, the 3 year total shareholder return of 119.73% points to much stronger longer term momentum that has cooled...

Urban Edge Properties (UE) is drawing attention after a mixed return picture. The stock has been roughly flat over the past year, while showing gains over the past 3 years and 5 years. See our latest analysis for Urban Edge Properties. The recent 7 day and 30 day share price returns of 3.57% and 4.11% declines, alongside a 6.14% decline over 90 days, suggest momentum has cooled recently even though the 3 year and 5 year total shareholder returns of 38.52% and 60.52% still point to a stronger...

If you are wondering whether Tripadvisor's current share price reflects its real worth, you are not alone. Many investors are asking whether the stock still offers value after a tough run. The shares last closed at US$13.99, with returns of a 5.7% decline over 7 days, 6.4% decline over 30 days, 4.4% decline year to date, 10.7% decline over 1 year, 35.8% decline over 3 years and 58.4% decline over 5 years. This performance has naturally raised questions about both risk and potential...

If you are wondering whether Gap's current share price really reflects its underlying value, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$27.28, with a 4.0% decline over the last 7 days, a 0.8% gain over 30 days, 8.3% gain year to date, 23.7% gain over 1 year, and a very large 3 year return that is around 1.4x, alongside a 46.3% gain over 5 years. These figures can change how investors think about both risk and opportunity. Recent...

Sana Biotechnology (SANA) used its appearance at the 44th Annual J.P. Morgan Healthcare Conference to share updated data on its UP421 cell therapy and pipeline programs SC451 and SG293, sharpening the story around its clinical progress. See our latest analysis for Sana Biotechnology. Those conference updates land after a mixed stretch for the stock, with a 7 day share price return of 3.32% compared with a 30 day share price return decline of 6.60%. Meanwhile, the 1 year total shareholder...

Why SPX Technologies is on investors’ radar today SPX Technologies (SPXC) has drawn fresh attention after recent trading left the stock around $213.61, with performance over the past month, past 3 months, and year giving investors more data to assess. See our latest analysis for SPX Technologies. The recent move to a share price of $213.61 comes after a 1-day share price return of 1.83% and a 7-day share price return of 2.97%, set against a 90-day share price return of 16.07% and a 1-year...

Context for Marvell Technology’s recent share performance Marvell Technology (MRVL) has seen its share price under pressure recently, with returns of 1% for the day, 3.7% over the past week, and a 4.4% decline over the past month. Over the past 3 months the stock is down 8.6%, and the 1 year total return is a 31.4% decline, even though the 3 year and 5 year total returns remain positive. See our latest analysis for Marvell Technology. At a share price of $80.38 and with a 1 year total...

Wondering whether Gentex shares offer fair value at around US$24, or if the current price is leaving something on the table for patient investors? The stock is roughly flat over the past month with a 0.3% return, but that sits against a 10.9% decline over the last year and a 28.7% decline over five years. This performance may have shifted how the market views its risk and potential. Recent coverage has focused on Gentex as an established auto parts name on the Nasdaq, with investors watching...

KeyBanc’s downgrade of Mach Natural Resources (MNR) to Sector Weight, tied to integration hurdles around new Central Basin Platform and San Juan Basin assets and reduced capital spending, has pushed investors to reassess the partnership’s near term outlook. See our latest analysis for Mach Natural Resources. At a share price of $11.01, Mach Natural Resources has seen pressure build over the past quarter, with a 90 day share price return of 7.25% and a 1 year total shareholder return decline...

If you are wondering whether W. P. Carey is fairly priced or if there is still value on the table, this article will walk you through what the current share price might be telling you. The stock last closed at US$68.92, with returns of 2.2% over 7 days, 6.1% over 30 days, 6.3% year to date, 31.3% over 1 year, 2.2% over 3 years, and 41.1% over 5 years. Taken together, these figures give you a broad picture of how the market has treated the shares across different time frames. Recent coverage...